One-Week radiation may cut lymphedema risk in breast cancer patients
NCT ID NCT04228991
First seen Nov 18, 2025 · Last updated May 15, 2026 · Updated 20 times
Summary
This study compares a 1-week radiation treatment to the standard 3-week schedule for women with node-positive breast cancer after surgery. The goal is to see if the shorter course is just as effective at preventing cancer from coming back while reducing the risk of lymphedema (arm swelling). About 588 participants will be followed for outcomes like recurrence, survival, and quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHEDEMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Allan Blair Cancer Centre
Regina, Saskatchewan, S4T 7T1, Canada
-
BC Cancer - Centre for the North
Prince George, British Columbia, Canada
-
BC Cancer - Centre for the Southern Interior
Kelowna, British Columbia, V1Y 5L3, Canada
-
BC Cancer - Vancouver Centre
Vancouver, British Columbia, V5Z 4E6, Canada
-
BC Cancer - Vancouver Island Centre
Victoria, British Columbia, V8R 6V5, Canada
-
CHU-de Québec-Université de Laval
Québec, Quebec, Canada
-
CHUM - Centre Hospitalier de L'Universite de Montreal
Montreal, Quebec, Canada
-
CIUSSS de l'Est-de-l'Île de Montréal, Hôpital, Maisonneuve-Rosemont
Montreal, Quebec, H1T 2M4, Canada
-
Cross Cancer Institute
Edmonton, Alberta, T6G 1Z2, Canada
-
Hotel-Dieu de Lévis (CISSS CA)
Lévis, Quebec, G6V 3Z1, Canada
-
Juravinski Cancer Centre
Hamilton, Ontario, L8V 5C2, Canada
-
London Regional Cancer Program
London, Ontario, N6A 5W9, Canada
-
McGill University Health Centre-Cedars Cancer Centre
Montreal, Quebec, H4A 3J1, Canada
-
Northeast Cancer Centre, Health Sciences North
Greater Sudbury, Ontario, P3E5J1, Canada
-
Princess Margaret Cancer Centre - UHN
Toronto, Ontario, M5G 1E0, Canada
-
Saskatoon Cancer Centre
Saskatoon, Saskatchewan, S7N 4H4, Canada
-
Sherbrooke University Hospital Centre
Sherbrooke, Quebec, J1G 2E8, Canada
-
Sunnybrook Health Sciences Centre - Odette Cancer Centre
Toronto, Ontario, M4N 3M5, Canada
-
The Ottawa Hospital Regional Cancer Centre
Ottawa, Ontario, K1H 8L6, Canada
-
Tom Baker Cancer Centre
Calgary, Alberta, T2N 4N2, Canada
Conditions
Explore the condition pages connected to this study.